Company launched by MD Anderson to be acquired by Abbott
IDEV Technologies’ next-generation stent technology attracts bid by industry leader
MD Anderson News Release 07/24/13
A private company based on technology discovered at The University of Texas MD Anderson agreed last week to be purchased by Abbott Laboratories, Inc., for $310 million.
IDEV Technologies, Inc., of Webster, Texas, has developed an innovative stent system to treat blockages in blood vessels...
From Prevention to Survivorship: The Obesity-Cancer Challenge
MD Anderson Backgrounder 07/19/13
With growing understanding of the links between obesity and cancer, MD Anderson Cancer Center...UT MD Anderson repeats as nation’s top hospital for cancer in annual survey
MD Anderson News Release 07-16-13
The University of Texas MD Anderson Cancer CenterAccording to the U.S. News & World Report’s...
Study shows African-American chronic lymphocytic leukemia patients don’t survive as long as others who receive similar treatment
UT MD Anderson, Duke researchers find blacks are treated quicker, have more advanced disease
MD Anderson News Release 07/11/13
African-Americans with chronic lymphocytic leukemia who receive standard treatments respond initially as well as non-African-Americans, yet do not survive as long, researchers report in a paper published online this week in CANCER, a journal of the American Cancer Society.
“These...
Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
Four pathways lead to creation of myofibroblasts that cause destructive runaway scarring
MD Anderson News Release 07/01...